Display options
Share it on

J Thorac Dis. 2014 Oct;6:S689-98. doi: 10.3978/j.issn.2072-1439.2014.09.25.

Atopic cough and fungal allergy.

Journal of thoracic disease

Haruhiko Ogawa, Masaki Fujimura, Noriyuki Ohkura, Koichi Makimura

Affiliations

  1. 1 Division of Pulmonary Medicine, Ishikawa-ken Saiseikai, Kanazawa Hospital, Kanazawa 920-0353, Japan ; 2 Respiratory Medicine, National Hospital Organization Nanao Hospital, Nanao 926-8531, Japan ; 3 Ishikawa Prefectural Central Hospital, Respiratory Medicine, Kanazawa, Japan ; 4 Laboratory of Space and Environmental Medicine, Graduate School of Medicine and Graduate School of Medical Technology, Teikyo University, Itabashi-ku Tokyo, Japan.

PMID: 25383202 PMCID: PMC4222924 DOI: 10.3978/j.issn.2072-1439.2014.09.25

Abstract

We have shown that some patients presenting with chronic bronchodilator-resistant non-productive cough have a global atopic tendency and cough hypersensitivity without nonspecific bronchial hyperresponsiveness, abbreviated as atopic cough (AC). The cough can be treated successfully with histamine H1 antagonists and/or glucocorticoids. Eosinophilic tracheobronchitis and cough hypersensitivity are pathological and physiological characteristics of AC. Fungus-associated chronic cough (FACC) is defined as chronic cough associated with basidiomycetous (BM) fungi found in induced sputum, and recognition of FACC has provided the possibility of using antifungal drugs as new treatment strategies. Bjerkandera adusta is a wood decay BM fungus, which has attracted attention because of its potential role in enhancing the severity of cough symptoms in FACC patients by sensitization to this fungus. Before making a diagnosis of "idiopathic cough" in cases of chronic refractory cough, remaining intractable cough-related laryngeal sensations, such as "a sensation of mucus in the throat (SMIT)," which is correlated with fungal colonization, should be evaluated and treated appropriately in each patient. The new findings, i.e., the detection of environmental mushroom spores that should not be present in the human airways in addition to the good clinical response of patients to antifungal drugs, may lead to the development of novel strategies for treatment of chronic cough.

Keywords: Atopic cough (AC); Bjerkandera adusta; cough variant asthma (CVA); cough-related laryngeal sensations; fungus-associated chronic cough (FACC)

References

  1. Lung. 2011 Dec;189(6):485-92 - PubMed
  2. Med Mycol. 2011 Apr;49 Suppl 1:S150-7 - PubMed
  3. Am J Respir Crit Care Med. 2011 Mar 15;183(6):708-15 - PubMed
  4. Sci Total Environ. 2009 Jun 1;407(12):3766-71 - PubMed
  5. Thorax. 2003 Jan;58(1):14-8 - PubMed
  6. J Voice. 2011 Sep;25(5):596-601 - PubMed
  7. Arerugi. 1982 Oct;31(10):1074-6 - PubMed
  8. Int Arch Allergy Immunol. 1998 Jun;116(2):162-5 - PubMed
  9. Clin Exp Allergy. 2000 Jan;30(1):41-7 - PubMed
  10. J Psychosom Res. 1995 Feb;39(2):203-13 - PubMed
  11. Respirology. 2013 Nov;18(8):1278-9 - PubMed
  12. Nihon Kokyuki Gakkai Zasshi. 2006 Mar;44(3):168-72 - PubMed
  13. Cough. 2013 Jan 14;9(1):1 - PubMed
  14. Chest. 2005 May;127(5):1710-3 - PubMed
  15. J Asthma. 2002 Jun;39(4):331-6 - PubMed
  16. Lancet. 1988 Jun 11;1(8598):1341 - PubMed
  17. Respirology. 2013 May;18(4):732-3 - PubMed
  18. Respirology. 2008 May;13(3):359-64 - PubMed
  19. Med Mycol J. 2011;52(3):205-12 - PubMed
  20. Can J Microbiol. 2001 Apr;47(4):277-82 - PubMed
  21. Pulm Pharmacol Ther. 2013 Oct;26(5):524-7 - PubMed
  22. Pulm Pharmacol Ther. 2011 Jun;24(3):334-8 - PubMed
  23. Lung. 2008;186 Suppl 1:S78-81 - PubMed
  24. Chest. 2006 Jan;129(1 Suppl):1S-23S - PubMed
  25. Allergol Int. 2013 Dec;62(4):517-8 - PubMed
  26. Lancet. 1989 Apr 22;1(8643):859-62 - PubMed
  27. Thorax. 2006 Sep;61 Suppl 1:i1-24 - PubMed
  28. J Allergy Clin Immunol. 2012 Jul;130(1):279-80; author reply 280 - PubMed
  29. Pulm Pharmacol Ther. 2014 Feb;27(1):127-8 - PubMed
  30. Respirology. 2012 Aug;17(6):964-8 - PubMed
  31. Lancet. 2012 Nov 3;380(9853):1540-1 - PubMed
  32. Pulm Pharmacol Ther. 2011 Oct;24(5):559-62 - PubMed
  33. Chem Immunol. 2002;81:28-47 - PubMed
  34. Am J Respir Crit Care Med. 2009 Jan 1;179(1):11-8 - PubMed
  35. Am Rev Respir Dis. 1990 Mar;141(3):640-7 - PubMed
  36. J Allergy Clin Immunol. 1976 May;57(5):480-8 - PubMed
  37. Thorax. 1991 Jul;46(7):479-83 - PubMed
  38. Lancet Respir Med. 2013 Jul;1(5):414-22 - PubMed
  39. J Asthma. 2009 Oct;46(8):849-55 - PubMed
  40. J Asthma. 2009 Feb;46(1):95-8 - PubMed
  41. Appl Microbiol Biotechnol. 1991 Jul;35(4):510-4 - PubMed
  42. J Asthma. 2009 May;46(4):407-12 - PubMed
  43. South Med J. 1966 Jan;59(1):64-74 - PubMed
  44. N Engl J Med. 1979 Mar 22;300(12):633-7 - PubMed
  45. J Allergy Clin Immunol. 2012 Feb;129(2):280-91; quiz 292-3 - PubMed
  46. J Clin Microbiol. 1997 May;35(5):1216-23 - PubMed
  47. Lung. 2011 Feb;189(1):73-9 - PubMed
  48. J Allergy Clin Immunol Pract. 2013 Sep-Oct;1(5):543 - PubMed
  49. Clin Exp Allergy. 2012 Oct;42(10):1540-1; author reply 1542-3 - PubMed
  50. Respirology. 2005 Mar;10(2):201-7 - PubMed
  51. Genome Res. 1997 Jun;7(6):649-56 - PubMed
  52. J Asthma. 1994;31(6):463-72 - PubMed
  53. Respirology. 2006 Sep;11 Suppl 4:S135-86 - PubMed
  54. Antimicrob Agents Chemother. 2001 Feb;45(2):633-5 - PubMed
  55. Thorax. 2003 Apr;58(4):339-43 - PubMed
  56. Respir Med. 2009 Oct;103(10):1492-7 - PubMed
  57. Pulm Pharmacol Ther. 2012 Feb;25(1):11 - PubMed
  58. Nature. 1952 Sep 6;170(4323):414 - PubMed
  59. J Asthma. 2010 Feb;47(1):51-4 - PubMed
  60. Chest. 2009 Apr;135(4):898-903 - PubMed
  61. Lancet. 2012 Nov 3;380(9853):1583-9 - PubMed
  62. Proc Am Thorac Soc. 2010 May;7(3):229-36 - PubMed
  63. Antimicrob Agents Chemother. 2013 Jun;57(6):2845-8 - PubMed

Publication Types